Nsp1 expression in cancer cells resulted in the down-regulation of several oncogenic or progrowth signaling pathways, including the mTOR and MAPK pathways, and up-regulation of the DNA damage marker p-H2AX (Figs. 1C and S1B), consistent with its anticancer activity. Here, SH2D3A is linked to cancer.